May. 17 2024
Source Page: Medical devices regulations: compliance and enforcementFound: suspected counterfeit medical device HTML Details Exemptions from devices regulations during the coronavirus
Report May. 17 2024
Committee: Statutory Instruments (Joint Committee)Found: Title Draft Coroners (Suspension of Requirement for Jury at Inquest: Coronavirus) Regulations 2024 Instruments
Written Evidence May. 16 2024
Inquiry: UK-EU data adequacyFound: A key example is the coronavirus pandemic, where we needed to share data quickly and responsibly to
May. 16 2024
Source Page: Criminal Justice System statistics quarterly: December 2023Found: non-motoring168 Public Health Offence1685716857 - Failure to comply with screening restriction/requirement (coronavirus
Written Evidence May. 15 2024
Inquiry: Climate change and securityFound: “We are forgotten”: forced migration, sexual and gender-based violence, and coronavirus disease-2019
May. 15 2024
Source Page: The People and Nature Surveys for England: Adults' Data Y4Q3 (October 2023 - December 2023)Found: natural spaces should be: Places that encourage physical health and exerciseThinking about life since the coronavirus
May. 15 2024
Source Page: The People and Nature Surveys for England: Adults' Data Y4Q3 (October 2023 - December 2023)Found: spaces should be: Places that encourage physical health and exercise Thinking about life since the coronavirus
Asked by: Christopher Chope (Conservative - Christchurch)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether (a) his Department and (b) the Medicines and Healthcare products Regulatory Agency has received data from Astra Zeneca on the potential serious adverse effects of its covid-19 vaccine for a small number of recipients.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Department has not directly received data from AstraZeneca regarding potential adverse effects of their COVID-19 vaccine Vaxzevria, as it is not the appropriate body to receive this information. It instead relies on the expert advice of the Medicines and Healthcare products Regulatory Agency (MHRA).
All vaccine manufacturers have a legal responsibility to mitigate risk and monitor the safety and performance of vaccines throughout the product lifecycle. This includes a legal responsibility to transmit reports of suspected adverse reactions received directly to the MHRA. Following the MHRA’s receipt of the first Yellow Card reports of suspected thrombosis and associated thrombocytopaenia associated with the Vaxzevria vaccine in February 2021, AstraZeneca provided the Commission on Human Medicines’ Vaccine Benefit Risk Expert Working Group an analysis of the age stratified risk of thrombosis with thrombocytopenia associated with the AstraZeneca vaccine. This was assessed by the Commission on Human Medicines, with the Patient Information updated to state the risks of these events.
Written Evidence May. 14 2024
Inquiry: Modern Slavery Act 2015Found: dhsc-publishes-review-of-risk-of-modern-slavery-and-human- trafficking-in-nhs-supply-chains/ 3 https://www.independent.co.uk/news/world/asia/coronavirus-chinese-companies-uighur-labour-face
Written Evidence May. 14 2024
Inquiry: Modern Slavery Act 2015Found: Since 2015, new risks, such as the coronavirus pandemic and the war in Ukraine, have exacerbated